214 related articles for article (PubMed ID: 25813354)
41. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
43. Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion.
Zheng F; Jang WC; Fung FK; Lo AC; Wong IY
PLoS One; 2016; 11(2):e0147961. PubMed ID: 26882120
[TBL] [Abstract][Full Text] [Related]
44. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X
Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002
[TBL] [Abstract][Full Text] [Related]
45. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
[TBL] [Abstract][Full Text] [Related]
46. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
47. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J
Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868
[TBL] [Abstract][Full Text] [Related]
48. The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model.
Woolf EC; Curley KL; Liu Q; Turner GH; Charlton JA; Preul MC; Scheck AC
PLoS One; 2015; 10(6):e0130357. PubMed ID: 26083629
[TBL] [Abstract][Full Text] [Related]
49. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
50. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
Kaluz S; Kaluzová M; Chrastina A; Olive PL; Pastoreková S; Pastorek J; Lerman MI; Stanbridge EJ
Cancer Res; 2002 Aug; 62(15):4469-77. PubMed ID: 12154057
[TBL] [Abstract][Full Text] [Related]
51. Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.
Grabmaier K; A de Weijert MC; Verhaegh GW; Schalken JA; Oosterwijk E
Oncogene; 2004 Jul; 23(33):5624-31. PubMed ID: 15184875
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme.
Fisher T; Galanti G; Lavie G; Jacob-Hirsch J; Kventsel I; Zeligson S; Winkler R; Simon AJ; Amariglio N; Rechavi G; Toren A
Cancer J; 2007; 13(5):335-44. PubMed ID: 17921733
[TBL] [Abstract][Full Text] [Related]
53. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
Birle DC; Hedley DW
Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
[TBL] [Abstract][Full Text] [Related]
54. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
[TBL] [Abstract][Full Text] [Related]
55. In vivo bioluminescence imaging monitoring of hypoxia-inducible factor 1alpha, a promoter that protects cells, in response to chemotherapy.
Viola RJ; Provenzale JM; Li F; Li CY; Yuan H; Tashjian J; Dewhirst MW
AJR Am J Roentgenol; 2008 Dec; 191(6):1779-84. PubMed ID: 19020250
[TBL] [Abstract][Full Text] [Related]
56. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
57. Effects of Far-infrared Ray on Temozolomide-treated Glioma in Rats.
Chen JC; Hwang JH
In Vivo; 2019; 33(4):1203-1208. PubMed ID: 31280210
[TBL] [Abstract][Full Text] [Related]
58. In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.
Saha D; Dunn H; Zhou H; Harada H; Hiraoka M; Mason RP; Zhao D
J Vis Exp; 2011 Oct; (56):. PubMed ID: 21989061
[TBL] [Abstract][Full Text] [Related]
59. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia.
Ding XC; Wang LL; Zhang XD; Xu JL; Li PF; Liang H; Zhang XB; Xie L; Zhou ZH; Yang J; Weichselbaum RR; Yu JM; Hu M
J Hematol Oncol; 2021 Jun; 14(1):92. PubMed ID: 34118979
[TBL] [Abstract][Full Text] [Related]
60. Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor.
Okamoto K; Ito D; Miyazaki K; Watanabe S; Tohyama O; Yokoi A; Ozawa Y; Asano M; Kawamura T; Yamane Y; Nagao S; Funasaka S; Kamata J; Kotake Y; Aoki M; Tsukahara N; Mizui Y; Tanaka I; Sawada K
Int J Mol Med; 2012 Apr; 29(4):541-9. PubMed ID: 22211243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
